SCYB Stock Overview
A technology company, provides platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Scryb Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.11 |
| 52 Week Low | CA$0.02 |
| Beta | 0.20 |
| 1 Month Change | 0% |
| 3 Month Change | -16.67% |
| 1 Year Change | -76.19% |
| 3 Year Change | -89.36% |
| 5 Year Change | -87.50% |
| Change since IPO | -88.64% |
Recent News & Updates
Shareholder Returns
| SCYB | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | -1.2% |
| 1Y | -76.2% | -31.0% | 10.5% |
Return vs Industry: SCYB underperformed the Canadian Medical Equipment industry which returned -31% over the past year.
Return vs Market: SCYB underperformed the Canadian Market which returned 10.5% over the past year.
Price Volatility
| SCYB volatility | |
|---|---|
| SCYB Average Weekly Movement | 28.2% |
| Medical Equipment Industry Average Movement | 10.6% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 17.4% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: SCYB has not had significant price volatility in the past 3 months.
Volatility Over Time: SCYB's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Yoav Raiter | www.scryb.ai |
Scryb Inc., a technology company, provides platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The company offers Cybeats, a supply chain cybersecurity and IoT device security solution; Software Bill of Materials Studio, a solution designed to manage and distribute software bill of materials in a single platform; Fionet Platform, an end-to-end testing and tracking technology solution for community-based or decentralized settings; and Pharmatrac, a system that predicts medication behavior. It also provides nutraceutical and cannabinoid-based products.
Scryb Inc. Fundamentals Summary
| SCYB fundamental statistics | |
|---|---|
| Market cap | CA$6.43m |
| Earnings (TTM) | -CA$14.05m |
| Revenue (TTM) | CA$2.05m |
3.1x
P/S Ratio-0.5x
P/E RatioIs SCYB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SCYB income statement (TTM) | |
|---|---|
| Revenue | CA$2.05m |
| Cost of Revenue | CA$1.64m |
| Gross Profit | CA$407.93k |
| Other Expenses | CA$14.45m |
| Earnings | -CA$14.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.055 |
| Gross Margin | 19.94% |
| Net Profit Margin | -686.59% |
| Debt/Equity Ratio | 4.0% |
How did SCYB perform over the long term?
See historical performance and comparison